Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.24M | -2.11M | -1.30M | -1.98M | -3.78M |
| Total Depreciation and Amortization | 196.00K | 202.00K | 221.00K | 164.00K | 132.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.64M | 545.00K | 1.31M | 1.00M | 1.12M |
| Change in Net Operating Assets | -2.09M | 789.00K | -2.76M | -2.72M | 1.29M |
| Cash from Operations | -3.49M | -572.00K | -2.53M | -3.54M | -1.23M |
| Capital Expenditure | -66.00K | -60.00K | -275.00K | -519.00K | -265.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -66.00K | -60.00K | -275.00K | -519.00K | -265.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00K | -5.00K | -6.00K | -4.00K | -5.00K |
| Issuance of Common Stock | 0.00 | 88.00K | 9.74M | 49.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -248.00K | 0.00 | 30.00K |
| Cash from Financing | -5.00K | 83.00K | 9.49M | 45.00K | 25.00K |
| Foreign Exchange rate Adjustments | 41.00K | -54.00K | -75.00K | -156.00K | -237.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.52M | -603.00K | 6.61M | -4.17M | -1.71M |